Perfil
Ashwin K.
Agarwal worked as Vice President of Corporate Strategy at Lundbeck Seattle BioPharmaceuticals, Inc. from 2016 to 2018.
He then worked as VP-Finance, Investor Relations & Treasury at Evolus, Inc. from 2018 to 2021.
Prior to that, he worked as Treasurer at Allergan, Inc. Mr. Agarwal completed his undergraduate degree at California State University-Fullerton and earned an MBA from USC Marshall School of Business.
Antiguos cargos conocidos de Ashwin K. Agarwal.
| Empresas | Cargo | Fin |
|---|---|---|
| EVOLUS, INC. | Contacto de Relaciones con Inversores | - |
| ALDER BIOPHARMACEUTICALS, INC. | Contacto de Relaciones con Inversores | 01/08/2018 |
| ALLERGAN, INC. | Contacto de Relaciones con Inversores | - |
Formación de Ashwin K. Agarwal.
| USC Marshall School of Business | Masters Business Admin |
| California State University-Fullerton | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| EVOLUS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Ashwin K. Agarwal
